The Center for Breakthrough Medicines (CBM) is a cell and gene therapy contract development and manufacturing organization (CDMO) uniquely positioned to enable pharma and biotech companies to develop, test, manufacture and market life-saving therapies and treatments on a global scale. Ideally located in the heart of Philadelphia’s Cellicon Valley, CBM has assembled the most accomplished cell and gene therapy experts in the world, armed with cutting-edge and innovative technologies, to offer scalable, best-in-class pre-clinical through commercial manufacturing capabilities including process development, plasmid DNA, viral vector manufacturing, cell banking, cell processing, and a full suite of complementary and standalone testing and analytical capabilities.

Purpose-built and patient-driven, CBM was designed from the ground up to be a more-effective CDMO; providing single-source, end-to-end solutions to deliver true partnership and unprecedented value to its customers through teamwork, transparency, and speed-to-market dedication.

CBM delivers:

  • Fully integrated services at a single site
  • Unrivaled experience building and optimizing processes for rapid product scale-up
  • Capacity available now for pre-clinical development through commercial GMP manufacturing of advanced therapies
  • Expert regulatory and quality support along the entire product pathway
  • Flexible cleanrooms aligned with client-specific workflows and equipment configurations

Our mission is to save lives by accelerating the development and manufacturing of Advanced Therapies.


The Center for Breakthrough Medicines

411 Swedeland Rd

King of Prussia, PA 19406


Phone: (866) 274-4009

Contact: info@cfbm.com